The cisplatin-based subgroup did not reach statistical significance over monotherapy.
← all excerpts
Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.
1
—
—
The cisplatin-based subgroup did not reach statistical significance over monotherapy.